PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Aurora Cannabis Inc. (ACB)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINCA05156X8843
CUSIP05156X884
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic

Highlights

Market Cap$352.32M
EPS-$57.50
Revenue (TTM)$275.88M
Gross Profit (TTM)$21.23M
EBITDA (TTM)-$33.33M
Year Range$2.84 - $11.50
Target Price$32.00
Short %20.42%
Short Ratio1.36

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Aurora Cannabis Inc.

Popular comparisons: ACB vs. CURLF, ACB vs. WEED.TO, ACB vs. OGI, ACB vs. CGC, ACB vs. PYPL, ACB vs. SNDL, ACB vs. FLGC

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Aurora Cannabis Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%150.00%NovemberDecember2024FebruaryMarchApril
-93.73%
156.58%
ACB (Aurora Cannabis Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Aurora Cannabis Inc. had a return of 40.91% year-to-date (YTD) and 17.70% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date40.91%5.84%
1 month59.38%-2.98%
6 months59.53%22.02%
1 year17.70%24.47%
5 years (annualized)-63.89%11.44%
10 years (annualized)N/A10.46%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-20.18%-17.39%39.81%
202321.82%-24.56%4.24%3.52%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of ACB is 62, suggesting that the investment has average results relative to the market in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.

The Risk-Adjusted Performance Rank of ACB is 6262
Aurora Cannabis Inc.(ACB)
The Sharpe Ratio Rank of ACB is 5555Sharpe Ratio Rank
The Sortino Ratio Rank of ACB is 7272Sortino Ratio Rank
The Omega Ratio Rank of ACB is 6868Omega Ratio Rank
The Calmar Ratio Rank of ACB is 5959Calmar Ratio Rank
The Martin Ratio Rank of ACB is 5555Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Aurora Cannabis Inc. (ACB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


ACB
Sharpe ratio
The chart of Sharpe ratio for ACB, currently valued at 0.16, compared to the broader market-2.00-1.000.001.002.003.004.000.16
Sortino ratio
The chart of Sortino ratio for ACB, currently valued at 1.42, compared to the broader market-4.00-2.000.002.004.006.001.42
Omega ratio
The chart of Omega ratio for ACB, currently valued at 1.16, compared to the broader market0.501.001.501.16
Calmar ratio
The chart of Calmar ratio for ACB, currently valued at 0.19, compared to the broader market0.002.004.006.000.19
Martin ratio
The chart of Martin ratio for ACB, currently valued at 0.44, compared to the broader market0.0010.0020.0030.000.44
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.05, compared to the broader market-2.00-1.000.001.002.003.004.002.05
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.98, compared to the broader market-4.00-2.000.002.004.006.002.98
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.501.001.501.36
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.55, compared to the broader market0.002.004.006.001.55
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 8.05, compared to the broader market0.0010.0020.0030.008.05

Sharpe Ratio

The current Aurora Cannabis Inc. Sharpe ratio is 0.16. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
0.16
2.05
ACB (Aurora Cannabis Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Aurora Cannabis Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-99.53%
-3.92%
ACB (Aurora Cannabis Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aurora Cannabis Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aurora Cannabis Inc. was 99.80%, occurring on Mar 14, 2024. The portfolio has not yet recovered.

The current Aurora Cannabis Inc. drawdown is 99.53%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.8%Jan 24, 20181545Mar 14, 2024
-78.02%Jan 12, 201554Sep 4, 2015232Sep 19, 2016286
-50.55%Jul 14, 20149Aug 1, 20144Sep 8, 201413
-39.39%Apr 11, 201737Jun 6, 201785Oct 5, 2017122
-36.61%Nov 21, 201613Dec 8, 201683Apr 10, 201796

Volatility

Volatility Chart

The current Aurora Cannabis Inc. volatility is 50.68%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%NovemberDecember2024FebruaryMarchApril
50.68%
3.60%
ACB (Aurora Cannabis Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Aurora Cannabis Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items